https://mbcbiolabs.com/wp-content/uploads/2025/04/TwoStep-Therapeutics-Logo.svgIntroduction to TwoStep Therapeutics and Fireside ChatTwoStep Therapeutics is a biotechnology company developing a pipeline built around a versatile targeting peptide “PIP” that binds selectively to multiple tumor-associated integrins, a unique feature that enables it to deliver various payloads to virtually any solid tumor. The company leverages this technology to create targeted cancer therapies for drug delivery and radioligand therapy. TwoStep Therapeutics was co-founded by CEO, Caitlyn Miller, in collaboration with world-renowned academic entrepreneurs at Stanford University, including Nobel Laureate Carolyn Bertozzi, Jennifer Cochran, and Ronald Levy. Come learn more about TwoStep Therapeutics, including an ‘ask me anything’-style Q&A at the end.Website → Our Speaker https://mbcbiolabs.com/wp-content/uploads/2025/04/CaitlynMiller_Headshot-300x200.jpg Dr. Caitlyn Miller Caitlyn Miller, PhD, co-founder and CEO of TwoStep Therapeutics, is dedicated to the company’s mission of bringing innovative targeted therapies to patients. Dr. Miller received her PhD in Bioengineering from Stanford University in the labs of Dr. Carolyn Bertozzi and Dr. Jennifer Cochran. During her PhD and postdoctoral work, Dr. Miller played a pivotal role in advancing technology that is now integrated into TwoStep’s therapeutic pipeline. Dr. Miller then joined the Stanford Innovative Medicines Accelerator as an Entrepreneur-In-Residence, where she spearheaded the launch of TwoStep Therapeutics. Register here →